Premium
The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents
Author(s) -
Donaghue K. C.,
Margan S. H.,
Chan A. K. F.,
Holloway B.,
Silink M.,
Rangel T.,
Bennetts B.
Publication year - 2005
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.2005.01631.x
Subject(s) - medicine , aldose reductase , diabetic neuropathy , diabetes mellitus , endocrinology , genetics , biology
Aims Variants in the aldose reductase gene (AKR1B1) have been implicated in the development of diabetic retinopathy and nephropathy, with the most convincing data identifying a (CA) n repeat microsatellite allele (Z−2), which has a functional role in gene expression. In this study the association between polymorphisms in the AKR1B1 gene and diabetic neuropathy was investigated. Methods The pupillary response to light was used as the major outcome in this study along with abnormal hot thermal threshold. Three hundred and sixty‐three adolescents underwent genotyping of the AKR1B1 gene. The microsatellite (CA) n repeat was sequenced and two single nucleotide polymorphisms, −106C→T and −12C→G, were investigated by restriction fragment length polymorphism. Results Seventy‐six percent of participants had pupillary abnormalities (45% with two, 15% with three abnormalities). Presence of the Z−2/Z−2 genotype increased the risk nearly three‐fold for pupillary abnormalities [odds ratio (OR) 3.02, 95% confidence interval (CI) 1.14, 7.98). The susceptibility genotypes (Z−2/Z−2 with −106C/−106C, Z−2/Z with −106C/−106C or Z/Z with −106C/−106C) were associated with resting pupil diameter abnormalities when compared with the protective genotypes (Z+2/Z+2 or −106T/−106T) (OR 2.83, 95% CI 1.25, 6.41). The combination of Z+2/−106T reduced the risk of abnormal heat discrimination (OR 0.48, 95% CI 0.23, 0.99). Conclusions In this study we have shown that Z−2/Z−2 genotype is significantly associated with the development of pupillary abnormality, an early indicator of diabetic autonomic neuropathy, in adolescent Australian patients with Type 1 diabetes.